ADI
62
3
AME
59
6
AMGN
31
-16
AON
67
-4
BBY
53
10
AN
43
-6
BMY
51
6
APD
52
-7
AMAT
60
6
ACN
43
-4
AMP
61
-2
AEE
66
-8
AIZ
66
-3
ADT
60
-3
ALL
43
-2
AES
38
-5
BDX
49
-10
AMT
46
-5
BA
42
3
AFL
45
-5
ADI
62
3
AME
59
6
AMGN
31
-16
AON
67
-4
BBY
53
10
AN
43
-6
BMY
51
6
APD
52
-7
AMAT
60
6
ACN
43
-4
AMP
61
-2
AEE
66
-8
AIZ
66
-3
ADT
60
-3
ALL
43
-2
AES
38
-5
BDX
49
-10
AMT
46
-5
BA
42
3
AFL
45
-5
Financhill
Back

Castle Biosciences Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

CSTL
Castle Biosciences

Last Price:
$16.32
Seasonality Move:
6.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Castle Biosciences Stock Forecast

  • Over the next 52 weeks, Castle Biosciences has on average historically fallen by 4.4% based on the past 5 years of stock performance.
  • Castle Biosciences has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Castle Biosciences Stock Undervalued?
    The current Castle Biosciences [CSTL] share price is $16.07. The Score for CSTL is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CSTL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Castle Biosciences Stock Go Up Next Year?

  • Over the next 52 weeks, Castle Biosciences has on average historically fallen by 4.4% based on the past 5 years of stock performance.

Castle Biosciences Stock Rating

Sell
38
Castle Biosciences (CSTL) is a Sell

Is Castle Biosciences overpriced?

  • Castle Biosciences has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Castle Biosciences Stock Price History

Is CSTL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CSTL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
castlebiosciences.com

52-Week Data

52-Week High:
35.84
52-Week Low:
15.45

Prediction Charts

Market Cap:
464M
Price in USD:
16.07
Volume:
288.5K
Beta:
0.92

Technical Analysis

SMA50:
17.95
SMA100:
18.87
SMA200:
24.05
52-Wk Change:
-16.78%

Stock Predictions

  • Is Castle Biosciences stock public?
    Yes, Castle Biosciences is a publicly traded company.
  • What is the Castle Biosciences stock quote today?
    The Castle Biosciences stock price is 16.07 USD today.
  • How to buy Castle Biosciences stock online?
    You can buy Castle Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-9 19.83 20.12 20.22 19.57
Jul-10 20.07 19.84 20.26 19.68
Jul-11 19.68 19.66 19.90 19.29
Jul-14 19.67 19.50 19.82 19.31
Jul-15 19.58 18.87 19.70 18.65
Jul-16 19.00 18.68 19.16 18.36
Jul-17 18.74 17.39 18.92 17.32
Jul-18 17.58 16.54 17.72 16.41
Jul-21 16.54 16.72 16.95 16.25
Jul-22 16.72 16.32 16.93 16.16
Jul-23 16.92 16.80 17.31 16.47
Jul-24 16.72 16.43 16.82 16.34
Jul-25 16.45 16.07 16.57 16.00
Jul-28 16.32 16.33 16.65 16.10

Castle Biosciences Earnings

Castle Biosciences Earnings Report: Per Share Castle Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Castle Biosciences Forecast Revenue Growth

Castle Biosciences Stock Analysis: Historical quarterly revenues per share for Castle Biosciences and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.66 per share, an increase next quarter of $0.09 per share, a decrease this year of $2.87 per share, and an increase next year of $0.54 per share.

* Castle Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.